Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation.
Doull
I
I
Langton-Hewer
S
S
D000681:Amylases / Q000009:adverse effects* / Q000627:therapeutic use; D001963:Bromelains / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004338:Drug Combinations; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced*; D007415:Intestinal Obstruction / Q000139:chemically induced*; D008049:Lipase / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome; D014357:Trypsin / Q000009:adverse effects* / Q000627:therapeutic use
D004338:Drug Combinations; C002762:Nutrizym; D001963:Bromelains; D008049:Lipase; D000681:Amylases; D014357:Trypsin